SCHEMBL31514595

SCHEMBL31514595

Cc1ccc(Nc2ncnc3cc(-c4ccc(N5CCOCC5)nc4)ccc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 1/20 0.51
▸ MAPT P10636 4/20 0.49
▸ MAPK1 P28482 3/20 0.49
▸ HTT P42858 2/20 0.49
▸ AHR P35869 1/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.48
▸ CNR2 P34972 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ EGFR P00533 2/20 0.46
▸ SRC P12931 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31514559 0.90 MAP4K4 (0.51) MAP4K4MAPTMAPK1HTTAHR
SCHEMBL31514626 0.90 CNR2 (0.54) MAP4K4MAPTMAPK1HTTAHR
SCHEMBL31514605 0.89 SRC (0.53) MAP4K4MAPTMAPK1HTTAHR
SCHEMBL31514587 0.89 EGFR (0.54) MAP4K4MAPK1HTTCNR2EGFR
SCHEMBL31514567 0.86 EGFR (0.49) MAP4K4MAPTMAPK1HTTAHR
SCHEMBL31514581 0.84 EGFR (0.54) MAP4K4CNR2EGFRCD38AURKB
SCHEMBL31514562 0.84 CNR2 (0.47) MAP4K4MAPK1CNR2ALDH1A1CYP1A2
SCHEMBL31514575 0.83 CNR2 (0.62) MAP4K4CNR2EGFRAURKB
SCHEMBL31514590 0.83 KDR (0.55) MAP4K4MAPK1HTTALDH1A1SMN1; SMN2
SCHEMBL31514568 0.83 RIPK2 (0.54) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119912429-A Quinazoline compound with anti-inflammatory activity or pharmaceutically acceptable salt thereof, pharmaceutical composition and application thereof 安徽医科大学 2025-05-02 — — CN disclosed
Send feedback